Clik here to view.
Making the T1D Vaccine a Reality
Nanoparticle-based vaccine is designed to re-educate the immune system and halt the attack on the pancreas Over the last three years, Selecta Bioscience, a clinical stage biotechnology company, has...
View ArticleClik here to view.
It’s Time to Redefine Type 1 Diabetes
Last month, JDRF co-hosted a workshop where healthcare experts from government, nonprofit agencies and educational institutions discussed expanding the definition of Type 1 Diabetes (T1D) to recognize...
View ArticleClik here to view.
Unlocking a Combination Therapy for New Onset T1D
A new study is further assessing if a novel combination of drugs could help treat new onset type 1 diabetes University of Florida researchers are ready to launch a new clinical study to examine if a...
View ArticleT1D Trial Looks to Teach an Old Drug New Tricks
JDRF-funded clinical study of a drug called TUDCA looks to improve beta cell functioning in people recently diagnosed with T1D Until recently, much of type 1 diabetes (T1D) research has focused on...
View ArticleInvestigating the Role of Regulatory T Cells in T1D
A video explains a potential new immune therapy in the words of the T1D investigator and one of the clinical study participants JDRF Research in the Field spoke to the lead investigator, Dr. Stephen...
View ArticleJDRF Draws a Winning Encapsulation Strategy
JDRF video demonstrates the differences between micro-encapsulation and macro-encapsulation A new video, “Sketching Encapsulation,” was created for JDRF’s FY2014 Annual Report. Albert J. Hwa, Ph.D.,...
View ArticleWell-Timed AP Technology Offers Peace of Mind in the UK
A JDRF-funded study at the University of Cambridge showed that an overnight treat-to-range device improved glucose control A recent JDRF-funded study at the University of Cambridge has found that...
View ArticleClik here to view.
Discovering the Best Size and Shape for Beta Cell Replacement
Watch this: To learn more from MIT’s Dr. Anderson. Smaller Is Not Always Stealthier In a recent Nature Materials’ publication, Daniel Anderson, Ph.D., of the Massachusetts Institute of Technology...
View ArticleClik here to view.
Understanding T1D through Organ Donation
nPOD provides much needed human tissues to cure type 1 diabetes In 2007, JDRF awarded a grant for more than $7 million to Mark Atkinson, Ph.D., at the University of Florida to a unique, first of its...
View Article
